Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Dr. Yo says inclusion criteria for eIND is very ch

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153924
(Total Views: 632)
Posted On: 01/01/2021 10:59:59 AM
Posted By: Enjay
Dr. Yo says inclusion criteria for eIND is very challenging

A Twitter follower of Dr. Yo posted the announcement of FDA providing guidance for inclusion/exclusion criteria under eIND. If you want to see the tweets, use this link:
https://twitter.com/YoDoctorYo/status/1344880468488028160

In case you don't follow Dr. Yo, he is an anesthesiologist. If he gets Leronlimab for this patient and posts the result, I will post on IH.
Here is the main gist of the thread:

Dr. Yo
@YoDoctorYo
9h
Going through this right now for a personal case. The new FDA inclusion criteria for eINDS is VERY challenging. The PEEP and PF ratios are new hurdles. Stay tuned.

TL
@ThipL12
9h
I can see your point with PEEP <15cmH2O being a challenge hurdle! But the phase 3 results analysis will be due out in late January in a short time. If results demonstrated efficacy, the FDA has moral obligations to give an approval or at the very least EUA!

Dr. Yo
@YoDoctorYo
9h
I don't have that long to wait. Need this eIND for my friends mom. Everyone on board but the PF ratio is the hurdle. If tomorrow we are over 150, should have Leronlimab on the ground Saturday morning to her. But got to clear that hurdle!

TL
@ThipL12
8h
When they’re on >15cmH2O of PEEP, I doubt S/C C19 patients should have PaO2 of >150 unless you also gave them 100% FIO2. To meet the criteria could you possibly wean down the FIO2 follows by an ABG later? I wish your friend’s Mom full speedy recovery..

Dr. Yo
@YoDoctorYo
8h
It gets tricky when trying to manipulate the FiO2 considering how severe the ARDS and poor oxygenating she is. But I think I bought her some time with ivermectin so hoping that we are able to cross the PF>150 tomorrow and get the greenlight.


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us